Buprenorphine and naloxone (Suboxone) is a mu-opioid receptor partial agonist and a kappa-opioid receptor antagonist used to treat opioid dependence.
Ed Sredzienski, MSPharm
Advertisement
Articles by Ed Sredzienski, MSPharm
Advertisement
Latest Updated Articles
Acute Pain Management for Patients Maintained on Buprenorphine and Naloxone TherapyPublished: September 21st 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
Court Ruling Highlights Risks of Improper Dose Adjustments
4
FDA Approves Single-Injection Maintenance Regimen of Mirikizumab-Mrkz for Ulcertive Colitis
5
